Quick10K

⚲

Acquired Sales

Filings

10-Q	2021-03-31	Filed 2021-05-17
10-K	2020-12-31	Filed 2021-03-31
10-Q	2020-09-30	Filed 2020-11-13
10-Q	2020-06-30	Filed 2020-08-19
10-Q	2020-03-31	Filed 2020-05-20
10-K	2019-12-31	Filed 2020-03-30
10-Q	2019-09-30	Filed 2019-11-15
S-1	2019-08-02	Public Filing
10-Q	2019-06-30	Filed 2019-08-14
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-03-13
10-Q	2018-09-30	Filed 2018-11-09
10-Q	2018-06-30	Filed 2018-10-05
10-Q	2018-03-31	Filed 2018-10-03
10-K	2017-12-31	Filed 2018-09-26
10-Q	2017-09-30	Filed 2018-09-19
10-Q	2017-06-30	Filed 2018-09-19
10-Q	2017-03-31	Filed 2018-09-18
10-K	2016-12-31	Filed 2018-09-06
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-13
10-K	2015-12-31	Filed 2016-03-28
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-12
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-31
10-Q	2014-09-30	Filed 2014-11-19
10-Q	2014-06-30	Filed 2014-08-14
10-Q	2014-03-31	Filed 2014-05-14
10-K	2013-12-31	Filed 2014-04-01
10-Q	2013-09-30	Filed 2013-11-14
10-Q	2013-06-30	Filed 2013-08-13
10-Q	2013-03-31	Filed 2013-05-17
10-K	2012-12-31	Filed 2013-04-01
10-Q	2012-09-30	Filed 2012-11-13
10-Q	2012-06-30	Filed 2012-08-13
10-Q	2012-03-31	Filed 2012-05-21
10-K	2011-12-31	Filed 2012-03-30
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-16
10-K	2010-12-31	Filed 2011-03-31
10-K	2010-09-30	Filed 2010-12-20
10-Q	2010-06-30	Filed 2010-08-23
10-Q	2010-03-31	Filed 2010-05-18
10-Q	2009-12-31	Filed 2010-02-16

Reports

8-K	2021-01-05
8-K	2020-12-18
8-K	2020-10-12
8-K	2020-09-09
8-K	2020-04-21
8-K	2020-02-24
8-K	2020-01-07
8-K	2019-11-14
8-K	2019-08-15
8-K	2019-07-29
8-K	2019-06-21
8-K	2019-05-23
8-K	2019-05-08
8-K	2019-04-30
8-K	2019-02-12
8-K	2018-11-18
8-K	2018-06-29

Acquired Sales Financials

AQSP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash					187	502	217	209	427	1,370	1,281	678	588	374	217	84	28	14	1	0	1	0	0	0	0	0	0	0	0	2,797	4,341	4,359
Accounts Receivable	615	88	575	238	292	23	0	0
Inventory
PP&E	57	52	56	40	2,314	5	4
Assets	717	219	1,250	1,011	863	1,099	1,953	1,535	1,427	1,370	1,281	1,305	1,234	1,040	994	84	53	14	1	0	1	0	0	0	0	0	0	0	0	2,797	6,239	6,556
Accounts Payable	429	401	332	416	346	137	94	19	21	51	26	58	25	48	52	13	19	29	53	105	92	95	102	104	106	109	112	110	113	21	22	7
Long-Term Debt	454		466	471	480		0	0																					31
Liabilities	3,671	3,116	3,338	3,434	4,172	395	202	169	41	51	26	58	25	48	52	13	19	29	57	109	149	169	192	210	228	248	267	297	339	180	86	104
Stockholders' Equity	-2,954	-2,897	-2,088	-2,423	-3,309	704	1,751	1,366	1,386	1,319	1,255	1,247	1,209	992	942	72	33	-16	-56	-109	-148	-169	-192	-210	-228	-248	-267	-297	-339	2,617	6,153	6,451


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	18	405	959	1,643			140
Cost of Revenue	0	192	316	483			104
Gross Profit	18	213	643	219			36
R&D
SG&A	696	2,002	1,008	745		74	82	81		75	72	104	60	239	74	53	38	49	40	53	-63	17	16	16	16	17	17	17		26	45	62
Tax		0	1	0				0		0	0	1	0									0				0	0	0		0	0	0
Net Income	-694	-1,809	-525	-479		3,742	1,046	-385	70	-67	253	-8	-5,182	-217	-50	-870	-38	-49	-40	-53		-20	-23	-18	-18	-20	-91	-35		-44	-897	-146


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-17	-503	31		-133	-285	77	-51	-37	-89	-0	-165	-214	-62	-92	-32	-39	-17	-0	4	-1	-0			0	0	0		-162	-185	-141
Cash Investing		-9	21	-0		3,670	0	-86	300	1,000	0	-602	75			-40	-25	25	0	0	0	0	0	0								-300
Cash Financing		92	460	40		-2,252		0	-30	-20	0	0								0	-4									2,959	3,625	459